Company / Inventory
Kura Oncology, Inc. Inventory History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$413.0K
FY2025
5-year range
$0 / $413.0K
FY2024-FY2025
Trend
-
vs FY2024
Sector context
#104 of 105
Health Care
What the data says
Among 105 Health Care companies, Kura Oncology, Inc. is in the bottom 1% for inventory.
Based on SEC 10-K filings.
$413,000 in FY2025.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 105This company $413.0K Sector average $885.3M
▼
-100.0% below sector average
Key checks
Key Insights
- Ranks #104 out of 105 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $413.0K | - |
| FY2024 | $0 | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026